Get the Stockscreener App
1.45
3.57%
0.05
Cibus Inc stock is traded at $1.45, with a volume of 324.60K.
It is up +3.57% in the last 24 hours and down -24.87% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.40
Open:
$1.4
24h Volume:
324.60K
Relative Volume:
0.52
Market Cap:
$110.61M
Revenue:
$3.64M
Net Income/Loss:
$-132.20M
P/E Ratio:
-0.4865
EPS:
-2.9806
Net Cash Flow:
$-51.17M
1W Performance:
-3.33%
1M Performance:
-24.87%
6M Performance:
-9.38%
1Y Performance:
-32.24%
1-Day Range:
$1.36
$1.47
1-Week Range:
$1.275
$1.525
52-Week Range:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.45 | 110.61M | 3.64M | -132.20M | -51.17M | -2.9806 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call - GlobeNewswire
Cibus, Inc. (NASDAQ:CBUS) Sees Large Growth in Short Interest - MarketBeat
Cibus (CBUS) to Release Earnings on Thursday - MarketBeat
Cibus (NASDAQ: CBUS) CFO receives stock and option grants - Stock Titan
Cibus (NASDAQ: CBUS) director granted 9,094 stock options at $1.50 strike - Stock Titan
Cibus (NASDAQ: CBUS) Sr VP awarded 38,000 shares and 76,000 options - Stock Titan
Cibus (CBUS) awards shares and stock options to CAO Jason Stokes - Stock Titan
Cibus (NASDAQ: CBUS) CFO awarded 57,000 shares and 114,000 options - Stock Titan
Cibus (CBUS) awards CSO 57K shares and 114K stock options - Stock Titan
Cibus (NASDAQ: CBUS) interim CEO Beetham granted 195K shares and 390K options - Stock Titan
CBUS Technical Analysis | Trend, Signals & Chart Patterns | CIBUS INC (NASDAQ:CBUS) - ChartMill
Cibus announces public offering of Class A common stock and pre-funded warrants - MSN
Cibus stock dips after pricing $15M offering - MSN
CBUS (Cibus Inc.) reports wider than expected Q4 2025 loss, shares fall 0.69% in today's trading session.Investment Signal Network - Cổng thông tin điện tử tỉnh Tây Ninh
Cibus (CBUS) Stock Pullback Trade (Slight Loss) 2026-04-20Community Driven Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
Should I hold Cibus (CBUS) stock (Smart Money Exits) 2026-04-20Investment Community Signals - Cổng thông tin điện tử tỉnh Lào Cai
[ARS] Cibus, Inc. SEC Filing - Stock Titan
Cibus (CBUS) seeks approval of directors, pay and auditor at 2026 virtual meeting - Stock Titan
What Analysts Say About Cibus (CBUS) Stock (Eye on Rally) 2026-04-18High Beta Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 earnings call transcript - MSN
Cibus (CBUS) director Urban Thomas reports zero Class A shares on Form 3 - Stock Titan
Cibus adds agribusiness veteran to board of directors By Investing.com - Investing.com Australia
Cibus adds agribusiness veteran to board of directors - Investing.com
Cibus Announces the Election of Thomas Urban to Board of Directors - ChartMill
Cibus, Inc. (NASDAQ:CBUS) Short Interest Update - MarketBeat
Cibus Strengthens Board with Appointment of Thomas Urban - The Globe and Mail
Cibus, Inc. 8-K Filing Details: Company Information, NASDAQ Listing, and Executive Changes April 2026 - Minichart
Cibus appoints Thomas Urban to board of directors By Investing.com - Investing.com Canada
Cibus appoints Thomas Urban to board of directors - Investing.com
Thomas Urban appointed to Cibus board - TradingView
New Cibus (CBUS) director Thomas Urban joins Board with cash and equity pay - Stock Titan
Cibus, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Can Cibus (CBUS) Stock Reach New Highs | Price at $2.02, Up 2.02%Global Trading Community - Xã Vĩnh Công
Cibus (CBUS) Sr VP withholds 1,763 shares for taxes, holds 101,879 - Stock Titan
Cibus (CBUS) CLO has 3,695 shares withheld to cover taxes - Stock Titan
Cibus (NASDAQ: CBUS) CFO reports 3,676-share tax-withholding disposition - Stock Titan
Cibus (NASDAQ: CBUS) CSO disposes 8,954 shares for tax withholding - Stock Titan
Cibus (CBUS) interim CEO Beetham disposes 16,112 shares for tax withholding - Stock Titan
What is HC Wainwright's Forecast for Cibus FY2029 Earnings? - MarketBeat
Pharma News: Whats the RSI of Cibus Inc stockQuarterly Portfolio Report & Precise Buy Zone Identification - baoquankhu1.vn
Cibus Launches Underwritten Public Offering of Common Stock - The Globe and Mail
Cibus launches underwritten offering of 6.98M shares at $2.15 to raise about $13.5M - TradingView — Track All Markets
Cibus (CBUS) prices underwritten stock sale, targeting up to $16M net - Stock Titan
Cibus prices $15 million public offering at $2.15 per share By Investing.com - Investing.com South Africa
Cibus (NASDAQ: CBUS) sells 6.98M Class A shares at $2.15 each - stocktitan.net
Analysts Conflicted on These Healthcare Names: Cibus (CBUS), Arrowhead Pharmaceuticals (ARWR) and Tarsus Pharmaceuticals (TARS) - The Globe and Mail
Cibus announces underwritten public offering of Class A shares By Investing.com - Investing.com Australia
Cibus prices $15 million public offering at $2.15 per share - Investing.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):